These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. Glioma grading: sensitivity, specificity, positive and negative predictive values of diffusion and perfusion imaging. Arvinda HR; Kesavadas C; Sarma PS; Thomas B; Radhakrishnan VV; Gupta AK; Kapilamoorthy TR; Nair S J Neurooncol; 2009 Aug; 94(1):87-96. PubMed ID: 19229590 [TBL] [Abstract][Full Text] [Related]
12. Persistent diffusion-restricted lesions in bevacizumab-treated malignant gliomas are associated with improved survival compared with matched controls. Mong S; Ellingson BM; Nghiemphu PL; Kim HJ; Mirsadraei L; Lai A; Yong W; Zaw TM; Cloughesy TF; Pope WB AJNR Am J Neuroradiol; 2012 Oct; 33(9):1763-70. PubMed ID: 22538078 [TBL] [Abstract][Full Text] [Related]
13. Increased diffusion in the normal appearing white matter of brain tumor patients: is this just tumor infiltration? Horváth A; Perlaki G; Tóth A; Orsi G; Nagy S; Dóczi T; Horváth Z; Bogner P J Neurooncol; 2016 Mar; 127(1):83-90. PubMed ID: 26614516 [TBL] [Abstract][Full Text] [Related]
14. Imaging biomarkers guided anti-angiogenic therapy for malignant gliomas. Kong Z; Yan C; Zhu R; Wang J; Wang Y; Wang Y; Wang R; Feng F; Ma W Neuroimage Clin; 2018; 20():51-60. PubMed ID: 30069427 [TBL] [Abstract][Full Text] [Related]
15. Decrease in the apparent diffusion coefficient in peritumoral edema for the assessment of recurrent glioblastoma treated by bevacizumab. Takano S; Kimu H; Tsuda K; Osuka S; Nakai K; Yamamoto T; Ishikawa E; Akutsu H; Matsuda M; Matsumura A Acta Neurochir Suppl; 2013; 118():185-9. PubMed ID: 23564129 [TBL] [Abstract][Full Text] [Related]
17. Improved perfusion MR imaging assessment of intracerebral tumor blood volume and antiangiogenic therapy efficacy in a rat model with ferumoxytol. Gahramanov S; Muldoon LL; Li X; Neuwelt EA Radiology; 2011 Dec; 261(3):796-804. PubMed ID: 21940504 [TBL] [Abstract][Full Text] [Related]
18. Percentage signal intensity recovery: A step ahead of rCBV in DSC MR perfusion imaging for the differentiation of common neoplasms of brain. Surendra KL; Patwari S; Agrawal S; Chadaga H; Nagadi A Indian J Cancer; 2020; 57(1):36-43. PubMed ID: 31898591 [TBL] [Abstract][Full Text] [Related]
19. Safety and maximum tolerated dose of superselective intraarterial cerebral infusion of bevacizumab after osmotic blood-brain barrier disruption for recurrent malignant glioma. Clinical article. Boockvar JA; Tsiouris AJ; Hofstetter CP; Kovanlikaya I; Fralin S; Kesavabhotla K; Seedial SM; Pannullo SC; Schwartz TH; Stieg P; Zimmerman RD; Knopman J; Scheff RJ; Christos P; Vallabhajosula S; Riina HA J Neurosurg; 2011 Mar; 114(3):624-32. PubMed ID: 20964595 [TBL] [Abstract][Full Text] [Related]